US 10626145
Peptide with anti-obesity and anti-diabetes activity and use thereof
granted A61KA61K38/00A61K38/08
Quick answer
US patent 10626145 (Peptide with anti-obesity and anti-diabetes activity and use thereof) held by CAREGEN CO., LTD. expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAREGEN CO., LTD.
- Grant date
- Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K38/08, A61K38/2264, A61K38/30